The Latest Cardiac and Vascular News
Successful completion of human factors program ahead of FUROSCIX NDA resubmission BURLINGTON, Mass.–(BUSINESS WIRE)–scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced a progress update on […]
BEDMINSTER, N.J., Dec. 12, 2019 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that it has entered into a feasibility evaluation with Genentech, a member of the Roche Group. This feasibility evaluation will involve the development of oral formulations using Matinas’ lipid nano-crystal (LNC) platform delivery technology, which […]
KFAR-SABA, Israel and ALISO VIEJO, Calif., Dec. 11, 2019 /PRNewswire/ — CathWorks today announced the approval of The CathWorks FFRangio™ System by the Japan’s Ministry of Health, Labour and Welfare (MHLW). The CathWorks FFRangio System is a non-invasive diagnostic technology that is used at the time of a routine angiography. The CathWorks FFRangio System transforms routine angiogram images […]
Maastricht, The Netherlands – 11th December 2019 Merit Medical Systems Inc., a leading manufacturer of proprietary devices used primarily in cardiology, radiology, oncology, and endoscopy, announces the commercial launch of the PreludeSYNC EVO radial compression device in European, Middle Eastern and African markets. The product has FDA clearance in the […]
Access to improved Adenocaine™ solution, a ready to administer heart arrest and cardioprotection innovation, is immediately available to hospitals nationwide SUGAR LAND, Texas, Dec. 9, 2019 /PRNewswire/ — QuVa Pharma, Inc. today announced it has signed a production and distribution agreement with Hibernation Therapeutics for its patented cardioplegia solution Adenocaine™, the combination of […]
Study Published in European Journal of Heart Failure Shows Significant and Sustained Improvement in Heart Function, Symptom Relief and Quality of Life Using Less Invasive Left Ventricular Enhancement Device SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., developer of the first less invasive system for left ventricular remodeling, today announced online publication of positive […]
ANDOVER, Mass., Dec. 04, 2019 (GLOBE NEWSWIRE) — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced the completion of the first successful adult human heart transplants from DCD (donation after circulatory […]
VANCOUVER, Dec. 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN): NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that it has been […]
Cardiac surgeons at Lucile Packard Children’s Hospital Stanford introduce the Ozaki procedure for pediatric patients STANFORD, Calif., Dec. 4, 2019 /PRNewswire/ — On Nov. 22, cardiothoracic surgeons at Lucile Packard Children’s Hospital Stanford began offering an innovative repair for children’s heart valves. The method, called the Ozaki procedure, involves crafting a new heart valve from the […]
EDEN PRAIRIE, Minn., Dec. 03, 2019 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced that Memphis, Tennessee-based health system, Methodist Le Bonheur, has initiated offering aquapheresis therapy to patients suffering from fluid overload using the company’s Aquadex FlexFlow system. The use of the therapy was featured in the Daily […]
